Does Biaxin XL Pak Oral Interact with other Medications?

Severe Interactions

These medications are not usually taken together. Consult your healthcare professional (e.g., doctor or pharmacist) for more in formation.

  • SELECTED MACROLIDES/SELECTED HMG-COA REDUCTASE INHIBITORS
  • CYP3A4 SUBSTRATES THAT PROLONG QT/POSACONAZOLE
  • STRONG CYP3A4 INHIBIT THAT PROLONG QT/PIMAVANSERIN (> 10 MG)
  • STRONG CYP3A4 INHIBITORS/MAVACAMTEN
  • STRONG CYP3A4 INHIBITORS THAT PROLONG QT/PACRITINIB
  • STR CYP3A4 INHIBITORS THAT PROLONG QT/PANOBINOSTAT (> 10 MG)
  • STRONG CYP3A4 INHIBITORS THAT PROLONG QT/LEVOKETOCONAZOLE
  • SELECTED STRONG CYP3A4 INHIBITORS/CONIVAPTAN
  • STRONG CYP3A4 INHIBITORS THAT PROLONG QT/ALFUZOSIN
  • STRONG CYP3A4 INHIBITORS/FINERENONE
  • STRONG CYP3A4 INHIBITORS/VOCLOSPORIN
  • STRONG CYP3A4 INHIBITORS THAT PROLONG QT/RANOLAZINE
  • STRONG AND MODERATE CYP3A4 INHIBITORS/LONAFARNIB
  • STRONG CYP3A4 INHIBITORS THAT PROLONG QT/IVABRADINE
  • STRONG CYP3A4 INHIBITORS/LUMATEPERONE (>10.5 MG)
  • STRONG CYP3A4 INHIBITORS/UBROGEPANT
  • SELECTED STRONG CYP3A4 INHIBITORS/ALPRAZOLAM; TRIAZOLAM
  • STRONG CYP3A4 INHIBITORS; ATAZANAVIR;DARUNAVIR/LERCANIDIPINE
  • STRONG & MOD 3A4 INHIB THAT PROLONG QT/CILOSTAZOL (> 50 MG)
  • STRONG CYP3A4 INHIBITORS/DAPAGLIFLOZIN-SAXAGLIPTIN-METFORMIN
  • STRONG AND MODERATE CYP3A4 INHIBITORS/ASUNAPREVIR
  • QT PROLONGING AGENTS/HYDROXYCHLOROQUINE
  • SELECTED QT PROLONGING AGENTS/SAQUINAVIR
  • STRONG OR MODERATE CYP3A4 INHIBITORS/LOMITAPIDE
  • SELECTED STRONG CYP3A4 INHIBITORS/ISAVUCONAZONIUM
  • STRONG CYP3A4 INHIBITORS/NALOXEGOL
  • QT PROLONGING AGENTS/ANAGRELIDE
  • STRONG CYP3A4 INHIBITORS/AVANAFIL
  • 3A4INHIB/DAPOXETINE;LEVOMILNACIPRAN(>80MG);VILAZODONE(>20MG)
  • STRONG OR MODERATE CYP3A4 INHIBITORS/FLIBANSERIN
  • CLARITHROMYCIN/ATORVASTATIN (> 20 MG); PRAVASTATIN (> 40 MG)
  • STRONG CYP3A4 INHIBITORS/SLT HIGH STRENGTH ANTIMUSCARINICS
  • SELECTED STRONG CYP3A4 INHIBITORS/DOMPERIDONE; CISAPRIDE
  • STRONG CYP3A4 INHIBITORS; PROTEASE INHIBITORS/TICAGRELOR
  • CLARITHROMYCIN; TELITHROMYCIN/LURASIDONE
  • STRONG CYP3A4 INHIB;ATAZANAV;DARUNAVIR/SAXAGLIPTIN (>2.5 MG)
  • STRONG CYP3A4 INHIBITORS; ATAZANAVIR; DARUNAVIR/DRONEDARONE
  • STRONG CYP3A4 INHIBITORS/TOLVAPTAN
  • QT PROLONGING AGENTS/DISOPYRAMIDE
  • STRONG CYP3A4 INHIBITORS/SILODOSIN; TAMSULOSIN
  • STRONG CYP3A4 INHIBITORS/EPLERENONE
  • STRONG CYP3A4 INHIBITORS/IRINOTECAN
  • QT PROLONGING AGENTS/SERTINDOLE
  • QT PROLONGING AGENTS/DROPERIDOL
  • SLT MACRO;KETOLIDE ANTIBIOTICS/ELETRIPTAN
  • QT PROLONGING AGENTS/LEVOMETHADYL
  • QT PROLONGING AGENTS/SPARFLOXACIN
  • QT PROLONGING AGENTS/HALOFANTRINE
  • QT PROLONGING AGENTS/BEPRIDIL
  • SELECTED MACROLIDE ANTIBIOTICS/PIMOZIDE
  • STRONG CYP3A4 INHIBITORS/VARDENAFIL (>2.5 MG)
  • SELECTED MACROLIDE ANTIBIOTICS/ERGOT ALKALOIDS
  • ANTIMICROBIALS/LIVE TYPHOID VACCINE
  • MACROLIDE ANTIBIOTICS/ASTEMIZOLE; TERFENADINE
  • Serious Interactions

    These medications may interact and cause very harmful effects. Consult your healthcare professional (e.g., doctor or pharmacist) for more in formation.

  • CLARITHROMYCIN; ERYTHROMYCIN/QUINUPRISTIN-DALFOPRISTIN
  • SELECTED MACROLIDES/SELECTED CALCIUM CHANNEL BLOCKERS
  • SENSITIVE CYP3A4; CYP2C9; CYP2C19 SUBSTRATES/ENZALUTAMIDE
  • SELECTED MACROLIDES/TACROLIMUS
  • SELECTED MACROLIDES/SIROLIMUS PROTEIN-BOUND
  • STRONG CYP3A4 INHIBITORS/MITAPIVAT
  • MACROLIDE ANTIBIOTICS/ORAL MIDAZOLAM
  • STR 3A4 INHIB PROL QT/TOLTERODINE (>1 MG IR OR >2 MG ER)
  • STR 3A4 INHIBITORS THAT PROLONG QT/PANOBINOSTAT (<= 10 MG)
  • STRONG CYP3A4 INHIBITORS/RIVOCERANIB
  • STRONG CYP3A4 INHIBITORS/DARIDOREXANT
  • STRONG CYP3A4 INHIBITORS/UPADACITINIB (>=30 MG)
  • STRONG CYP3A4 INHIBITORS/RUPATADINE
  • SELECT CYP3A4 INHIBITORS THAT PROLONG QT/TRAZODONE
  • STRONG & MODERATE 3A4 INHIB THAT PROLONG QT/ENCORAFENIB
  • STRONG CYP3A4 INHIBITORS/SURUFATINIB
  • STRONG CYP3A4 INHIBITORS/AVACOPAN
  • STRONG CYP3A4 INHIBITORS THAT PROLONG QT/RIBOCICLIB
  • SELECTED QT PROLONGING AGENTS/INTRAVENOUS LEFAMULIN
  • STRONG CYP3A4 INHIBITORS THAT PROLONG QT/MOBOCERTINIB
  • STRONG 3A4 INHIBITORS THAT PROLONG QT/BEDAQUILINE;DELAMANID
  • STRONG & MODERATE 3A4 INHIBITOR THAT PROLONG QT/FEXINIDAZOLE
  • STRONG CYP3A4 INHIB THAT PROLONG QT/ARTEMETHER;LUMEFANTRINE
  • OATP1B1-3 INHIBITORS/BRINCIDOFOVIR
  • STRONG AND MODERATE CYP3A4 INHIBITORS/INFIGRATINIB
  • STRONG CYP3A4 INHIBITORS THAT PROLONG QT/GLASDEGIB
  • DUAL STRONG CYP3A4 INHIBITOR & P-GP INHIBITORS/TEPOTINIB
  • P-GLYCOPROTEIN (P-GP) INHIBITORS/RELUGOLIX
  • STRONG CYP3A4 INHIBITORS THAT PROLONG QT/TOREMIFENE
  • STRONG CYP3A4 INHIBITORS THAT PROLONG QT/SUNITINIB
  • STRONG CYP3A4 INHIBITORS THAT PROLONG QT/PAZOPANIB
  • STRONG CYP3A4 INHIBITORS THAT PROLONG QT/NILOTINIB
  • STRONG CYP3A4 INHIBITORS THAT PROLONG QT/LAPATINIB
  • STRONG CYP3A4 INHIBITORS THAT PROLONG QT/DASATINIB
  • STRONG CYP3A4 INHIBITORS THAT PROLONG QT/CRIZOTINIB
  • STRONG CYP3A4 INHIBITORS THAT PROLONG QT/CERITINIB
  • STRONG CYP3A4 INHIBITORS THAT PROLONG QT/BOSUTINIB
  • STRONG CYP3A4 INHIBITORS/VINFLUNINE
  • STRONG CYP3A4 INHIBITORS/VINCRISTINE
  • STRONG CYP3A4 INHIBITORS/VINBLASTINE
  • STRONG CYP3A4 INHIBITORS/TOFACITINIB
  • STRONG CYP3A4 INHIBITORS/SONIDEGIB
  • STRONG CYP3A4 INHIBITORS/RUXOLITINIB
  • STRONG CYP3A4 INHIBITORS/PONATINIB
  • STRONG CYP3A4 INHIBITORS/PALBOCICLIB
  • STRONG CYP3A4 INHIBITORS/PACLITAXEL
  • STRONG CYP3A4 INHIBITORS/OLAPARIB
  • STRONG CYP3A4 INHIBITORS/IXABEPILONE
  • STRONG CYP3A4 INHIBITORS/IDELALISIB
  • STRONG CYP3A4 INHIBITORS/ERLOTINIB
  • STRONG CYP3A4 INHIBITORS/DOXORUBICIN
  • STRONG CYP3A4 INHIBITORS/DOCETAXEL
  • STRONG CYP3A4 INHIBITORS/DABRAFENIB
  • STRONG CYP3A4 INHIBITORS/COBIMETINIB
  • STRONG CYP3A4 INHIBITORS/CABOZANTINIB
  • STRONG CYP3A4 INHIBITORS/CABAZITAXEL
  • STRONG CYP3A4 INHIBITORS/AXITINIB
  • STRONG CYP3A4 INHIBITORS/SUVOREXANT
  • QT PROLONGING AGENTS/LEVOMEPROMAZINE
  • STRONG CYP3A4 INHIBITORS THAT PROLONG QT/IVOSIDENIB
  • STRONG CYP3A4 AND P-GP INHIBITORS/PRALSETINIB
  • STRONG CYP3A4 INHIBITORS/PLITIDEPSIN
  • STRONG CYP3A4 INHIBITORS THAT PROLONG QT/VEMURAFENIB
  • STRONG AND MODERATE CYP3A4 INHIBITORS/LURBINECTEDIN
  • STRONG CYP3A4 INHIBITORS THAT PROLONG QT/QUETIAPINE
  • STRONG CYP3A4 INHIBITORS THAT PROLONG QT/SELPERCATINIB
  • STRONG AND MODERATE CYP3A4 INHIBITORS/PEMIGATINIB
  • STRONG AND MODERATE CYP3A4 INHIBITORS/SELUMETINIB
  • STRONG CYP3A4 INHIBITORS THAT PROLONG QT/OSILODROSTAT
  • QT PROLONGING AGENTS/OXALIPLATIN
  • STRONG CYP3A4 INHIBITORS/RIMEGEPANT
  • STRONG CYP3A4 INHIBITORS/NIMODIPINE
  • STRONG CYP3A4 INHIBITORS THAT PROLONG QT/ROMIDEPSIN
  • STRONG CYP3A4 INHIBITORS/TAZEMETOSTAT
  • STRONG CYP3A4 INHIBITORS/AVAPRITINIB
  • STRONG AND MODERATE CYP3A4 INHIBITORS/LEMBOREXANT
  • STRONG CYP3A4 INHIBITORS/ELEXACAFTOR-TEZACAFTOR-IVACAFTOR
  • STRONG CYP3A4 INHIBITORS/NALDEMEDINE
  • STRONG CYP3A4 INHIBITORS/ISTRADEFYLLINE
  • STRONG & MOD CYP3A4 INHIBITOR THAT PROLONG QT/ORAL LEFAMULIN
  • STRONG CYP3A4 INHIBITORS THAT PROLONG QT/ENTRECTINIB
  • STRONG CYP3A4 INHIBITORS/FEDRATINIB
  • STRONG CYP3A4 INHIBITORS/PEXIDARTINIB
  • SELECTED STRONG CYP3A4 INHIBITORS/CLOPIDOGREL
  • STRONG CYP3A4 INHIBITORS/LAROTRECTINIB
  • STRONG CYP3A4 INHIBITORS/LORLATINIB
  • P-GLYCOPROTEIN (P-GP) INHIBITORS/TALAZOPARIB
  • STRONG CYP3A4 INHIBITORS/DUVELISIB
  • CLARITHROMYCIN; ERYTHROMYCIN; VERAPAMIL/RIVAROXABAN
  • STRONG CYP3A4 INHIBITORS/ELAGOLIX
  • STRONG CYP3A4 INHIBITORS/ARIPIPRAZOLE LAUROXIL SUBMICRONIZED
  • QT PROLONGING AGENTS/LOFEXIDINE
  • STRONG AND MODERATE CYP3A4 INHIBITORS/TEZACAFTOR-IVACAFTOR
  • QT PROLONGING AGENTS/MACIMORELIN
  • STRONG CYP3A4 INHIBITORS/IBRUTINIB
  • STRONG CYP3A4 INHIBITORS/ACALABRUTINIB
  • STRONG CYP3A4 INHIBITORS/ABEMACICLIB
  • STRONG CYP3A4 INHIBITORS/COPANLISIB
  • QT PROLONGING AGENTS/INOTUZUMAB OZOGAMICIN
  • STRONG CYP3A4 INHIB;MODERATE 3A4 & P-GP DUAL INHIB/NERATINIB
  • STRONG CYP3A4 INHIBITORS/BRIGATINIB
  • STRONG CYP3A4 INHIBITORS/VALBENAZINE
  • STRONG AND MODERATE CYP3A4 INHIBITORS/DEFLAZACORT
  • SLT STRONG 3A4 INHIBITORS/SILDENAFIL(PAH);TADALAFIL(BPH,PAH)
  • SELECTED ANTIBIOTICS/CHOLERA VACCINE LIVE
  • QT PROLONGING AGENTS/HYDROXYZINE
  • STRONG CYP3A4 INHIBITORS/VENETOCLAX
  • QT PROLONGING AGENTS/TELAVANCIN
  • QT PROLONGING AGENTS/SORAFENIB
  • QT PROLONGING AGENTS/ONDANSETRON
  • QT PROLONGING AGENTS/LEVOMETHADONE; METHADONE
  • QT PROLONGING AGENTS/LENVATINIB
  • QT PROLONGING AGENTS/GADOFOSVESET
  • QT PROLONGING AGENTS/EZOGABINE
  • QT PROLONGING AGENTS/ARSENIC
  • QT PROLONGING AGENTS/OSIMERTINIB
  • STRONG CYP3A4 INHIBITORS/TRABECTEDIN
  • QT PROLONGING AGENTS/SULPIRIDE
  • QT PROLONGING AGENTS/PROPOFOL
  • QT PROLONGING AGENTS/PENTAMIDINE
  • QT PROLONGING AGENTS/FLUCONAZOLE
  • QT PROLONGING AGENTS/DONEPEZIL
  • QT PROLONGING AGENTS/CHLORPROMAZINE
  • QT PROLONGING AGENTS/CHLOROQUINE
  • QT PROLONGING AGENTS/SOTALOL
  • QT PROLONGING AGENTS/PROCAINAMIDE
  • QT PROLONGING AGENTS/IBUTILIDE
  • QT PROLONGING AGENTS/HYDROQUINIDINE; QUINIDINE
  • QT PROLONGING AGENTS/FLECAINIDE
  • STRONG CYP3A4 INHIBITORS/CARIPRAZINE
  • SLT STRONG CYP3A4 INHIBITOR & SUBSTRATE/LUMACAFTOR-IVACAFTOR
  • STRONG CYP3A4 INHIBITORS/TRASTUZUMAB EMTANSINE
  • STRONG 3A4 INHIBITORS/ESZOPICLONE > 2 MG; ZOPICLONE > 5 MG
  • STRONG CYP3A4 INHIBITORS/DACLATASVIR
  • QT PROLONGING AGENTS/CITALOPRAM
  • STRONG & MODERATE CYP3A4 INHIBITORS/ELIGLUSTAT
  • STRONG CYP3A4 INHIBITORS/VORAPAXAR
  • STRONG & MODERATE CYP3A4 INHIBITORS/GUANFACINE
  • STRONG OR MODERATE CYP3A4 INHIBITORS/SIMEPREVIR
  • STRONG CYP3A4 INHIBITORS/MACITENTAN
  • DUAL STRONG CYP3A4 INHIBITOR & P-GP INHIBITORS/RIOCIGUAT
  • STRONG AND MODERATE CYP3A4 INHIBITORS/BOSENTAN
  • QT PROLONGING AGENTS/DOFETILIDE
  • STRONG CYP3A4 INHIBITORS/REGORAFENIB
  • STRONG CYP3A4 INHIBITORS; AMPRENAVIR;ATAZANAVIR/MIFEPRISTONE
  • STRONG AND MODERATE CYP3A4 INHIBITORS/IVACAFTOR
  • SELECTED P-GLYCOPROTEIN (P-GP) INHIBITORS/ALISKIREN
  • QT PROLONGING AGENTS/VANDETANIB
  • QT PROLONGING AGENTS/PROPAFENONE
  • CLARITHROMYCIN; TELITHROMYCIN/SALMETEROL
  • STRONG CYP3A4 INHIBITORS/EVEROLIMUS
  • P-GLYCOPROTEIN (P-GP) INHIBITORS/TOPOTECAN
  • QT PROLONGING AGENTS/ZUCLOPENTHIXOL
  • STRONG CYP3A4 INHIBITORS/MARAVIROC
  • QT PROLONGING AGENTS/PALIPERIDONE
  • SELECTED QT PROLONGING AGENTS/ZIPRASIDONE
  • STRONG CYP3A4 INHIBITORS; ATAZANAVIR/COLCHICINE
  • SELECTED CYP3A4 INHIBITORS/SELECTED OPIOIDS
  • QT PROLONGING AGENTS/AMIODARONE
  • CLARITHROMYCIN; ERYTHROMYCIN; TELITHROMYCIN/RIFAMYCINS
  • QT PROLONGING AGENTS/MESORIDAZINE
  • QT PROLONGING AGENTS/THIORIDAZINE
  • SELECTED MACROLIDES/SELECTED IMMUNOSUPPRESSANTS;TEMSIROLIMUS
  • MACROLIDE ANTIBIOTICS/DIGOXIN, ORAL
  • MACROLIDE ANTIBIOTICS/CARBAMAZEPINE
  • SLT MACROLIDE ANTIBIOTICS/SLT ANTICOAGULANTS (VIT K ANTAG)
  • Moderate Interactions

    These medications may cause some risk when taken together. Consult your healthcare professional (e.g., doctor or pharmacist) for more in formation.

  • CLARITHROMYCIN/SELECTED PROTEASE INHIBITORS
  • CLARITHROMYCIN/NNRTIS
  • CLARITHROMYCIN/QT PROLONGING AGENTS
  • CLARITHROMYCIN; ERYTHROMYCIN/SELECTED STRONG CYP3A4 INDUCERS
  • STRONG CYP3A4 INHIBITORS THAT PROLONG QT/CLOZAPINE
  • STRONG CYP3A4 INHIBITORS/LUMATEPERONE (<=10.5 MG)
  • QT PROLONGING AGENTS/SAVOLITINIB
  • QT PROLONGING AGENTS/TRICLABENDAZOLE
  • STRONG CYP3A4 INHIBITORS THAT PROLONG QT/GILTERITINIB
  • STR 3A4 INHIB THAT PROL QT/TOLTERODINE (<=1 MG OR <=2 MG ER)
  • STRONG CYP3A4 INHIBITORS/UPADACITINIB (<30 MG)
  • STRONG CYP3A4 INHIBITORS/ATOGEPANT
  • QT PROLONGING AGENTS/OZANIMOD
  • QT PROLONGING AGENTS/PONESIMOD
  • QT PROLONGING AGENTS/SIPONIMOD
  • STRONG CYP3A4 INHIBITORS THAT PROLONG QT/MIDOSTAURIN
  • STRONG CYP3A4 INHIBITORS/IBREXAFUNGERP
  • STRONG CYP3A4 INHIBIT THAT PROLONG QT/PIMAVANSERIN (<=10 MG)
  • QT PROLONGING AGENTS/GALANTAMINE
  • STRONG CYP3A4 INHIBITORS/REPAGLINIDE
  • STRONG CYP2D6 OR CYP3A4 INHIBITORS/OLICERIDINE
  • STRONG CYP3A4 INHIBITORS/FOSTAMATINIB
  • QT PROLONGING AGENTS/AMISULPRIDE
  • STRONG CYP3A4 INHIBITORS/CANNABIDIOL-TETRAHYDROCANNABINOL
  • SELECTED STRONG CYP3A4 INHIBITORS/MEFLOQUINE
  • STRONG CYP3A4 INHIBITORS/ZANUBRUTINIB
  • STRONG CYP3A4 INHIBITORS THAT PROLONG QT/ILOPERIDONE
  • STRONG CYP3A4 INHIBITORS/BREXPIPRAZOLE
  • QT PROLONGING AGENTS/PITOLISANT
  • CLARITHROMYCIN/ROSUVASTATIN
  • SELECT P-GP INHIBITORS/EDOXABAN (<= 30 MG)
  • STRONG CYP3A4 INHIBITORS/CLONAZEPAM
  • SELECTED P-GLYCOPROTEIN (P-GP) INHIBITORS/BETRIXABAN
  • SELECTED MACROLIDE ANTIBIOTICS/BROMOCRIPTINE; CABERGOLINE
  • QT PROLONGING AGENTS/ERIBULIN
  • SELECT P-GP INHIBITORS/EDOXABAN (> 30 MG)
  • P-GP AND SELECTED CYP3A4 INHIBITORS/NINTEDANIB
  • STRONG 3A4 INHIB/LEVOMILNACIPRAN(<=80MG);VILAZODONE(<=20MG)
  • P-GLYCOPROTEIN (P-GP) INHIBITORS/AFATINIB
  • CLARITHROMYCIN/ATORVA(<=20 MG); PITAVA; PRAVASTATIN(<=40 MG)
  • QT PROLONGING AGENTS/FINGOLIMOD
  • STRONG CYP3A4 INHIBITORS/VARDENAFIL (<=2.5 MG)
  • STRONG CYP3A4 INHIB;ATAZANAV;DARUNAVIR/SAXAGLIPTIN(<=2.5 MG)
  • CYP3A4; CYP2C8; P-GLYCOPROTEIN (P-GP) INHIBITORS/LOPERAMIDE
  • STRONG CYP3A4 INHIBITORS/BUSPIRONE
  • STRONG CYP3A4 INHIBITORS/ESZOPICLONE; ZOPICLONE; ZOLPIDEM
  • STRONG CYP3A4 INHIBITORS/CINACALCET
  • CLARITHROMYCIN; TELITHROMYCIN/SELECTED ANTIDIABETIC AGENTS
  • STRONG CYP3A4 INHIBITORS; ATAZANAVIR; DARUNAVIR/ARIPIPRAZOLE
  • STRONG CYP3A4 INHIBITORS/SLT LOW STRENGTH ANTIMUSCARINICS
  • MACROLIDE ANTIBIOTICS/MIDAZOLAM
  • STRONG & MOD 3A4 INHIB THAT PROLONG QT/CILOSTAZOL (<=50MG)
  • SLT STRONG CYP3A4 INHIBITORS/SILDENAFIL (ED); TADALAFIL (ED)
  • SELECTED P-GLYCOPROTEIN (P-GP) INHIBITORS/ETOPOSIDE
  • SELECTED MACROLIDE ANTIBIOTICS/CORTICOSTEROIDS
  • SELECTED MACROLIDE ANTIBIOTICS/SELECTED XANTHINE DERIVATIVES
  • Free RX Coupon

    Save up to 80% on your prescriptions.

    Available coupons

    Save up to 80% on your prescription with WebMDRx

    Drug Survey

    Are you currently using Biaxin XL Pak Oral?

    This survey is being conducted by the WebMD marketing sciences department.

    Selected from data included with permission and copyrighted by First Databank, Inc. This copyrighted material has been downloaded from a licensed data provider and is not for distribution, except as may be authorized by the applicable terms of use.

    CONDITIONS OF USE: The information in this database is intended to supplement, not substitute for, the expertise and judgment of healthcare professionals. The information is not intended to cover all possible uses, directions, precautions, drug interactions or adverse effects, nor should it be construed to indicate that use of a particular drug is safe, appropriate or effective for you or anyone else. A healthcare professional should be consulted before taking any drug, changing any diet or commencing or discontinuing any course of treatment.